CFM
DNA icon

Comprehensive Financial Management’s Ginkgo Bioworks DNA Stock Holding History

Comprehensive Financial Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Hold
17,656
– – ﹤0.01% 36
2025
Q4 		$147K Hold
17,656
– – ﹤0.01% 35
2025
Q3 		$257K Hold
17,656
– – 0.01% 38
2025
Q2 		$199K Hold
17,656
– – 0.01% 41
2025
Q1 		$101K Hold
17,656
– – ﹤0.01% 38
2024
Q4 		$173K Hold
17,656
– – ﹤0.01% 38
2024
Q3 		$144K Sell
17,656
-2
-0% -$20 ﹤0.01% 40
2024
Q2 		$236K Hold
17,658
– – 0.01% 39
2024
Q1 		$819K Hold
17,658
– – 0.03% 30
2023
Q4 		$1.19M Hold
17,658
– – 0.04% 25
2023
Q3 		$1.28M Hold
17,658
– – 0.05% 27
2023
Q2 		$1.31M Hold
17,658
– – 0.04% 29
2023
Q1 		$939K Hold
17,658
– – 0.03% 32
2022
Q4 		$1.19M Buy
+17,658
New +$1.62M 0.04% 31

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return